Please click on links to see full press coverage:
Drug Discovery news A small molecule inhibitor blocks breast cancers back up plan
FierceBiotech | Targeting treatment-resistant BRCA-mutated tumors via the newly discovered POLQ pathway |
BioWorld | Artios heads to the clinic with first ever POLQ inhibitor trial |
Pharmatimes | Researchers identify new drug class with potential in BRCA-mutated tumours |
FirstWordPharma | New drug class could treat range of cancers with faulty BRCA genes |
Bloomberg | Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase Inhibitor in Nature |
BioSpace | Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase Inhibitor in Nature Communications |
The Independent | Scientists identify ‘hugely exciting’ new drugs that could lead to cancer treatments |
The Daily Mail | Hope for women with the ‘Angelina Jolie’ gene as scientists find drugs that can kill cancer cells but leave healthy ones unharmed |
Benzinga | Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase Inhibitor in Nature Communications |
News Medical Life Sciences | Novel drug class shows potential to treat cancer patients with faulty BRCA genes |
Newsbreezer | New class of drugs shows potential for treating cancer patients with defective BRCA genes |
Telegraph & Argus | Hope as new drugs to help treat breast and prostate cancer identified |
Industry Update | Targeting treatment-resistant BRCA mutant tumors via the newly discovered POLQ pathway |
Messenger | Hope as new drugs to help treat breast and prostate cancer identified |
IrishNews | Hope as new drugs to help treat breast and prostate cancer identified |
EurekAlert | New drug class could treat range of cancers with faulty BRCA genes |
Gazettelive | New cancer drug breakthrough could treat diseases triggered by ‘Angelina Jolie gene’ |
DailyPost | New cancer drug breakthrough could treat diseases triggered by ‘Angelina Jolie gene’ |
Bristolpost | New cancer drug breakthrough could treat diseases triggered by ‘Angelina Jolie gene’ |
Newsazi | Artios Pharma Publishes Preclinical Data On The First Selective Small Molecule Polθ Polymerase Inhibitor In Nature Communications |
Market Newswire | Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase Inhibitor in Nature Communications |